scholarly article | Q13442814 |
P356 | DOI | 10.1016/0924-977X(92)90037-9 |
P953 | full work available at URL | https://api.elsevier.com/content/article/PII:0924977X92900379?httpAccept=text/plain |
https://api.elsevier.com/content/article/PII:0924977X92900379?httpAccept=text/xml | ||
P698 | PubMed publication ID | 1638175 |
P2093 | author name string | L. Oreland | |
J. Harro | |||
J. Marcusson | |||
P2860 | cites work | Protein measurement with the Folin phenol reagent | Q20900776 |
Development of a class of selective cholecystokinin type B receptor antagonists having potent anxiolytic activity | Q28334293 | ||
Distinct cholecystokinin receptors in brain and pancreas | Q28366068 | ||
A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples | Q29615292 | ||
Cholecystokinin-tetrapeptide induces panic attacks in patients with panic disorder | Q34205234 | ||
Suicide and panic disorder: a review | Q37273543 | ||
Evidence for an involvement of the brain cholecystokinin B receptor in anxiety | Q37395948 | ||
Neuropeptide-containing neurons of the cerebral cortex are also GABAergic | Q37574159 | ||
Cholecystokinin-dopamine interactions | Q37756133 | ||
Cholecystokinin and anxiety | Q37948721 | ||
Anxiogenic-like action of caerulein, a CCK-8 receptor agonist, in the mouse: influence of acute and subchronic diazepam treatment | Q41225777 | ||
Anxiety, Aging and the Third Emergency Reaction | Q41568008 | ||
Enhanced sensitivity to cholecystokinin tetrapeptide in panic disorder. Clinical and behavioral findings | Q41936389 | ||
Benzodiazepine binding sites in amygdala and hippocampus of depressed suicide victims | Q42051743 | ||
CCK receptors and human neurological disease | Q42452516 | ||
Comparison of the effects of cholecystokinin-tetrapeptide and carbon dioxide in healthy volunteers | Q43658284 | ||
Evaluation of the effects of PD 134308 (CI-988), A CCK-B antagonist, on the punished responding of squirrel monkeys | Q43801694 | ||
Stress-induced changes in cholecystokinin and substance P concentrations in discrete regions of the rat hypothalamus | Q43818519 | ||
Regionally selective increases in mu opioid receptor density in the brains of suicide victims | Q44338653 | ||
Characterization of central cholecystokinin receptors using a radioiodinated octapeptide probe | Q44482344 | ||
Cholecystokinin receptors in brain: Effects of obesity, drug treatment, and lesions | Q45305739 | ||
A comparative study on characterization and distribution of cholecystokinin binding sites among the rat, mouse and guinea pig brain | Q46388947 | ||
Occurrence of two cholecystokinin binding sites in guinea-pig brain cortex | Q46798688 | ||
Regulation of central cholecystokinin recognition sites by guanyl nucleotides | Q48104929 | ||
Two brain cholecystokinin receptors: implications for behavioral actions | Q48417682 | ||
Reduced high affinity cholecystokinin binding in hippocampus and frontal cortex of schizophrenic patients | Q48522864 | ||
Different populations of GABAergic neurons in the visual cortex and hippocampus of cat contain somatostatin- or cholecystokinin- immunoreactive material | Q48619810 | ||
'Anxiolytic' effect of CCK-antagonists on plus-maze behavior in mice | Q48722219 | ||
Rats with anxious or non-anxious type of exploratory behaviour differ in their brain CCK-8 and benzodiazepine receptor characteristics | Q48893448 | ||
Long-term diazepam treatment produces changes in cholecystokinin receptor binding in rat brain | Q48895561 | ||
Investigation of behavioral and electrophysiological responses induced by selective stimulation of CCKB receptors by using a new highly potent CCK analog, BC 264. | Q48906138 | ||
CCK8 effects on motivational and emotional states of rats involve CCKA receptors of the postero-median part of the nucleus accumbens | Q48918859 | ||
The behavioral effects of CCK8 injected into the medial nucleus accumbens are dependent on the motivational state of the rat. | Q48924190 | ||
Further analysis of the effects of cholecystokinin octapeptides on avoidance behaviour in rats | Q49022819 | ||
Autoradiographic analysis of [3H]ketanserin binding in the human brain postmortem: effect of suicide | Q49131163 | ||
Cholecystokinin tetrapeptide induces panic-like attacks in healthy volunteers. Preliminary findings. | Q51176483 | ||
Classification and function of CCK receptors | Q60054779 | ||
Brain GABAA/benzodiazepine binding sites and glutamic acid decarboxylase activity in depressed suicide victims | Q69847915 | ||
Evidence that CCKB receptors mediate the regulation of exploratory behaviour in the rat | Q70198484 | ||
Cholecystokinin receptors: biochemical demonstration and autoradiographical localization in rat brain and pancreas using [3H] cholecystokinin8 as radioligand | Q70202430 | ||
Cholecystokinin Receptors in the Brain: Characterization and Distribution | Q72851367 | ||
Responsiveness of mesolimbic, mesocortical, septal and hippocampal cholecystokinin and substance P neuronal systems to stress, in the male rat | Q84269422 | ||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | suicide | Q10737 |
neurology | Q83042 | ||
pharmacology | Q128406 | ||
cholecystokinin | Q60315441 | ||
P304 | page(s) | 57-63 | |
P577 | publication date | 1992-03-01 | |
P1433 | published in | European Neuropsychopharmacology | Q15286536 |
P1476 | title | Alterations in brain cholecystokinin receptors in suicide victims | |
P478 | volume | 2 |
Q38245264 | An overview of the neurobiology of suicidal behaviors as one meta-system. |
Q90130243 | Blockade of the cholecystokinin CCK-2 receptor prevents the normalization of anxiety levels in the rat |
Q44341298 | Central d-Ala2-Met5-enkephalinamide μ/δ-opioid receptor activation blocks behavioral sensitization to cholecystokinin in CD-1 mice |
Q48423881 | Changes in cholecystokinin receptor binding in rat brain after selective damage of locus coeruleus projections by DSP-4 treatment |
Q47737537 | Cholecystokinin and psychiatric disorders : role in aetiology and potential of receptor antagonists in therapy |
Q51097201 | Cholecystokinin in CSF from depressed patients: possible relations to severity of depression and suicidal behaviour. |
Q52050031 | Cholecystokinin peptides and receptor binding in Alzheimer's disease. |
Q71594365 | Cholecystokinin peptides and receptors in the rat brain during stress |
Q48657997 | Cholecystokinin tetrapeptide-induced calcium mobilization in T cells of patients with panic disorder, major depression, or schizophrenia |
Q48826100 | Effects of chronic lithium and electroconvulsive stimuli on cholecystokinin mRNA expression in the rat brain |
Q30476895 | Elevated cholecystokininergic tone constitutes an important molecular/neuronal mechanism for the expression of anxiety in the mouse |
Q91666421 | GWAS studies reveal a possible genetic link between cancer and suicide attempt |
Q37372982 | Interaction between cholecystokinin and the fibroblast growth factor system in the ventral tegmental area of selectively bred high- and low-responder rats. |
Q40655459 | Pharmacologic treatment of brain failure and delirium. |
Q48252985 | Social isolation of rats increases the density of cholecystokinin receptors in the frontal cortex and abolishes the anti-exploratory effect of caerulein |
Q41940141 | The role of neuropeptides in suicidal behavior: a systematic review |
Search more.